- Ziv, Elad;
- Wu, Alan;
- Province, MA;
- Goetz, MP;
- Brauch, H;
- Flockhart, DA;
- Hebert, JM;
- Whaley, R;
- Suman, VJ;
- Schroth, W;
- Winter, S;
- Zembutsu, H
The International Tamoxifen Pharmacogenomics Consortium was established to address the controversy regarding cytochrome P450 2D6 (CYP2D6) status and clinical outcomes in tamoxifen therapy. We performed a meta-analysis on data from 4,973 tamoxifen-treated p